Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, February 07, 2014
Northwest Biotherapeutics, Inc. (NASDAQ: NWBO)
(“NW Bio”), a biotechnology company developing non-toxic DCVax® personalized immune
therapies for solid tumor cancers, announced today that Dr. Marnix Bosch, Chief Technical Officer of
NW Bio, will ...
read more
Friday, February 07, 2014
Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio),
a biotechnology company developing DCVax® personalized immune therapies for solid tumor
cancers, announced today that it has entered into a set of agreements for large-scale expansion of
the ...
read more
Monday, February 08, 2016
Nuvo Research has agreed with Horizon Pharma to extend the term of their manufacturing agreement for the production of PENNSAID® 2% for the U.S. market to December 31, 2029, which extends the agreement by an additional seven years.
read more
Nuvo Pharmaceuticals announced the signing of a letter of intent with Aralez Pharmaceuticals to acquire a portfolio of more than 20 products, as well as the associated personnel and infrastructure.
read more
Thursday, January 23, 2020
Nuvisan Pharma Services has announced its acquisition of Inamed GmbH, an international CRO specialized in clinical trials with patients living with respiratory and rare diseases.
read more
Tuesday, October 06, 2015
Nuventra has announced that David Y. Mitchell, Ph.D. will serve as the company’s new Chief Scientific Officer (CSO).
read more
Nutriband has signed an exclusive 20-year, $90 million distribution agreement for its transdermal consumer product lines with Best Choice.
read more
Monday, September 07, 2020
Nutriband has completed the acquisition of Pocono Coated Product's Transdermal and Health product manufacturing business effective August 31, 2020.
read more
Nutriband announced that it has completed commercial manufacturing process scale-up for its lead product, Aversa™ Fentanyl, with Kindeva, a global contract development and manufacturing organization (CDMO) focused on drug-device combination products.
read more
Wednesday, January 24, 2018
Nutra Pharma is partnering with EuroAmerican IP to distribute their Over-the-Counter (OTC) pain reliever, Nyloxin Topical Gel.
read more
Nusano Inc., a physics company producing medical radioisotopes, and PharmaLogic Holdings Corp., a radiopharmaceutical contract development and manufacturing organization ("CDMO"), announced a supply agreement to provide a more efficient and reliable ...
read more
Wednesday, September 17, 2025
NurExone Biologic announced that its U.S. subsidiary, Exo-Top Inc., is planning to establish its first U.S. commercial exosome production facility in Indianapolis, Indiana.
read more
Numerate, Inc., a computational drug design company applying artificial intelligence (AI) at cloud scale to transform small molecule drug discovery, announced the formation of a multi-year agreement with Takeda Pharmaceutical Company Limited under ...
read more
Tuesday, February 18, 2020
Nucleus Biologics announced a complete line of cGMP grade media and a new supplement to enable improved insulin response and standardized processing of human pancreatic islets and beta cells.
read more
To mark its 10th anniversary, NuChem Sciences, Canada's largest contract research organization (CRO) in drug discovery chemistry, recently inaugurated its new laboratories located on Dobrin Street in Montreal.
read more